By Monya Baker of Nature magazine The first company to test a human embryonic stem-cell product in patients has become the first big player to bail out of the field. [More]
Read More »By Monya Baker of Nature magazine The first company to test a human embryonic stem-cell product in patients has become the first big player to bail out of the field. [More]
Read More »